Smart Money Gobbles Up Calls In BILI

As the markets start to move higher, traders' risk appetite increases. What are they buying or selling? For that, I like to look at my Dollar Ace scanner. You see, everyone who trades options on the U.S. markets must disclose their trades to the Options Pricing Reporting Authority. In plain English that means whoever places an options trade, whether it's you, me, or Carl Icahn—the information must be made publicly available. My Dollar Ace scanner detects large and unusual option trades in real-time. And while I don’t work at a hedge fund, I get to see a lot of their trades. Today I want to talk to you about some action I saw Friday morning. The trade was in Bilibili (BILI), an online entertainment services company out of China. And unlike the rest of the market, the stock is actually up more than 50% on the year. Here’s what I saw: An options player came in the morning and bought $229,000 worth of May 20 $35 calls. These are deep out-the-money options that are set to expire worthless—unless the stock makes a move up within the next month. But it’s worth noting the company announces earnings on May 11th. I typically don’t trade unusual options activity on earnings stocks because there is too much noise. However, there is a creative way you can play this. For example, one of my favorite strategies is the catalyst runup. That’s when you buy a stock or option ahead of the catalyst and get out before. The idea is simple. As the catalyst approaches more speculators will come in and drive the price higher. The downside is limited because it’s unlikely the stock will drop hard because traders are still waiting for the catalyst news. That said, if you’re looking for a stock that could continue its momentum, look no further than BILI. Now, [I’ve put together a masterclass](on how this all works. People who have taken it are experiencing wildly successful results. After taking the [Dollar Ace Masterclass]( you too will be able to find these hidden opportunities in the market. In fact, you’ll be shocked at how easy it is to make money following it. [Register here to jump into the class.]( [It’s 100% free and worth every second of your time.]( The market is starting to pivot, are you positioned to take advantage of it? Sign up for the Dollar Ace Masterclass today. Kyle Dennis [Special]( RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 [Click Here to stop receiving emails from kyle@biotechbreakouts.com]( [Unsubscribe from all RagingBull emails]( Neither Kyle Dennis nor RagingBull.com, LLC (publisher of BiotechBreakouts) is registered as an investment adviser nor a broker/dealer with either the U. S. Securities & Exchange Commission or any state securities regulatory authority. Users of this website are advised that all information presented on this website is solely for informational purposes, is not intended to be used as a personalized investment recommendation, and is not attuned to any specific portfolio or to any user's particular investment needs or objectives. The owners, employees and writers of RagingBull.com may engage in securities trading that is discussed or viewed on this website, but all such individuals are buying and selling such securities for their own account. These individuals do not engage in any trades with customers. The buying and selling of securities by these individuals is not part of a regular business of buying and selling securities. Past performance is NOT indicative of future results. Furthermore, such information is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell (short or otherwise) any security. All users of this website must determine for themselves what specific investments to make or not make and are urged to consult with their own independent financial advisors with respect to any investment decision. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. All opinions, analyses and information included on this website are based on sources believed to be reliable and written in good faith, but should be independently verified, and no representation or warranty of any kind, express or implied, is made, including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. In addition, we undertake no responsibility to notify such opinions, analyses or information or to keep such opinions, analyses or information current. Also be aware that owners, employees and writers of and for RagingBull.com, LLC may have long or short positions in securities that may be discussed on this website or newsletter, but all such positions are held for such representative’s own account. Past results are not indicative of future profits. This table is accurate, though not every trade is represented. Profits and losses reported are actual figures from the portfolios Kyle Dennis manages on behalf of RagingBull.com, LLC. If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com.